Shandong Sinobioway Biomedicine Co., Ltd. (SHE:002581)
China flag China · Delayed Price · Currency is CNY
7.57
+0.02 (0.26%)
Feb 4, 2026, 3:04 PM CST

SHE:002581 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
325.3506.4151.91183.8187.8284.15
Cash & Short-Term Investments
325.3506.4151.91183.8187.8284.15
Cash Growth
-24.14%233.35%-17.35%-2.13%-33.91%-74.65%
Accounts Receivable
199.4793.32172.62179.72272.96353.77
Other Receivables
113.4252.2478.8718.3613.4916.75
Receivables
312.89145.55251.49198.09286.45370.52
Inventory
127.3279.6485.3180.0464.3370.87
Other Current Assets
19.3515.417.9956.4329.8840.62
Total Current Assets
784.85747.01496.71518.36568.45766.16
Property, Plant & Equipment
325.51274.74357.84705.47713.76684.72
Long-Term Investments
936.411,0561,3551,5031,223751.21
Other Intangible Assets
97.893.47108.29126.32134.29144.55
Long-Term Deferred Tax Assets
21.3711.216.1211.8425.2825.14
Long-Term Deferred Charges
0.210.321.415.27.787.72
Other Long-Term Assets
48.4713.4412.260.4983.3665.46
Total Assets
2,2152,1962,3372,8702,7562,445
Accounts Payable
83.5835.3573.6943.6442.1314.46
Accrued Expenses
7.9620.8322.519.3231.0132.34
Short-Term Debt
37.532.7713.84150.42151.54118.5
Current Portion of Leases
21.730.17-13.4615.8320.82
Current Income Taxes Payable
2.56-0.951.20.440.65
Current Unearned Revenue
1.0510.463.5926.863.431.21
Other Current Liabilities
32.5313.0319.03109.3814.1718.9
Total Current Liabilities
186.9482.61133.61364.28258.54206.87
Long-Term Debt
8.51-----
Long-Term Leases
3.07-0.711.479.827.77
Long-Term Unearned Revenue
5.495.495.496.719.7410.96
Long-Term Deferred Tax Liabilities
9.789.397.517.688.688.74
Other Long-Term Liabilities
7.7276.1216.099.67--
Total Liabilities
221.51173.61163.41389.82286.76254.33
Common Stock
229.15229.15229.15229.15229.15229.15
Additional Paid-In Capital
880.95866.41873.93858.5858.29858.29
Retained Earnings
759.27828.08965.391,2981,3011,030
Total Common Equity
1,8691,9242,0682,3852,3882,117
Minority Interest
123.7498.67105.2694.9481.1173.43
Shareholders' Equity
1,9932,0222,1742,4802,4692,191
Total Liabilities & Equity
2,2152,1962,3372,8702,7562,445
Total Debt
70.842.9414.55165.35177.16167.09
Net Cash (Debt)
254.46503.47137.3618.4510.64117.06
Net Cash Growth
-40.63%266.52%644.38%73.50%-90.91%-43.55%
Net Cash Per Share
0.390.760.210.030.020.18
Filing Date Shares Outstanding
659.56659.74659.74659.74659.74659.74
Total Common Shares Outstanding
659.56659.74659.74659.74659.74659.74
Working Capital
597.91664.4363.1154.08309.91559.3
Book Value Per Share
2.832.923.143.623.623.21
Tangible Book Value
1,7721,8301,9602,2592,2541,973
Tangible Book Value Per Share
2.692.772.973.423.422.99
Buildings
-393.55486.08639.62612.92426.35
Machinery
-431.4432.25413.16424.47345.34
Construction In Progress
-38.1122.1791.4364.86353.63
Source: S&P Global Market Intelligence. Standard template. Financial Sources.